A system hybridizing cardiac contractility modulation and implantable cardioverter defibrillation successfully converted ...

Heart failure (HF) is a complex and rapidly increasing syndrome, with an estimated prevalence of 1.1–5.5 per cent, accounting ...

The American Medical Association’s CPT editorial panel will meet May 1-3 to consider codes for several devices and services, but the most important of these might be the code for cardiac contractility ...

CCM is the brand name for cardiac contractility modulation — the non-excitatory electrical pulses delivered by the implantable Optimizer device to improve heart contraction. CCM therapy sends unique ...

The INTEGRA-D ™ trial is a multicenter, prospective, single-arm study evaluating the safety and efficacy of CCM-D ® HF System ...

Marlton, NJ, April 28, 2025 (GLOBE NEWSWIRE) — Impulse Dynamics® plc, a global medical device company dedicated to improving the lives of people with heart failure (HF), is proud to announce ...